Point Of Care Hiv Serology Diagnostic And/Or Supplemental Test
QSU · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3956
Classification
FDA Product Code
QSU
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3956
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
Human immunodeficiency virus (HIV) Point of Care serological diagnostic and supplemental tests are prescription devices for the qualitative detection of HIV antigen(s) and/or detection of antibodies against HIV in human body fluids or tissues.